Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
02/2014
02/18/2014US8653239 Method for isolating polypeptides
02/18/2014US8653237 Peptide analogues
02/18/2014US8653034 Compositions and methods comprising phosphatidylethanolamine-binding peptide derivatives
02/18/2014US8653032 Pharmaceutical composition for preventing / treating TRPV1 activity-related and inflammation-related diseases or conditions containing maillard peptide separated from well-aged traditional soy sauce as active ingredient
02/18/2014US8652843 DDR1-binding agents and methods of use thereof
02/18/2014US8652842 Humanized immunoglobulin loci
02/18/2014US8652487 Tolerogenic synthetic nanocarriers for inducing regulatory B cells
02/18/2014US8652485 Peptide for vaccine
02/18/2014US8652479 Antibody-drug conjugates and methods
02/18/2014US8652476 Pharmaceutical composition for treating ischemic events
02/18/2014US8652475 Inhibition of factor B, the alternative complement pathway and methods related thereto
02/18/2014US8652474 Composition comprising antibody that binds to domain II of HER2 and acidic variants thereof
02/18/2014US8652473 Antibodies to EGF receptor epitope peptides and uses thereof
02/18/2014US8652472 Compositions and methods for diagnosing and treating cancer
02/18/2014US8652466 Methods for the treatment of disease using immunoglobulins having Fc regions with altered affinities for FcγRactivating and FcγRinhibiting
02/18/2014US8652465 Methods and compositions for the treatment of persistent infections
02/18/2014US8652462 Immune regulation
02/18/2014CA2708753C Peptide diagnostic agent for lyme disease
02/18/2014CA2674838C Anti-ige vaccines
02/18/2014CA2633468C Novel neurotrophic factor protein and uses thereof
02/18/2014CA2601267C Novel anti-plgf antibody
02/18/2014CA2585011C Chlamydia trachomatis antigens for vaccine and diagnostic use
02/18/2014CA2577183C Mutated hiv nef for modulating immunity
02/18/2014CA2576627C Angiogenic and immunologic applications of anti-cd160 specific compounds obtainable from mab cl1-r2
02/18/2014CA2574654C Compositions and methods of use for mgd-csf in disease treatment
02/18/2014CA2564076C Chemical linkers and conjugates thereof
02/18/2014CA2562604C Preparation of scfv antibody fragments
02/18/2014CA2547034C Anticarcinoma antibodies and uses thereof
02/18/2014CA2507898C Immunoglobulin variants and uses thereof
02/18/2014CA2503315C Procedure for obtaining cell lines in a protein-free media and cell line obtained by the method
02/18/2014CA2403313C Potent t cell modulating molecules
02/13/2014WO2014026033A1 Cross-reactive t cell epitopes of hiv, siv, and fiv for vaccines in humans and cats
02/13/2014WO2014025828A1 Engineered antibody fragments for targeting and imaging cd8 expression in vivo
02/13/2014WO2014025546A2 Anti-dengue virus antibodies and uses thereof
02/13/2014WO2014024514A1 Protein purification method
02/13/2014WO2014023952A2 Prevention and treatment of osteoarthritis
02/13/2014WO2014023709A1 Asgpr antibodies and uses thereof
02/13/2014WO2014023679A1 Composition comprising two antibodies engineered to have reduced and increased effector function
02/13/2014WO2014023673A1 Interleukin-10 fusion proteins and uses thereof
02/13/2014WO2014023315A1 Multimerization through beta-strand swapping in ccp domains
02/13/2014WO2013188864A3 Anti-cd22 anti-idiotypic antibodies and uses thereof
02/13/2014WO2013168108A3 Biparatopic binding polypeptides for cxcr2 and uses thereof
02/13/2014WO2013167883A9 Single domain binding molecule
02/13/2014WO2013164789A3 Lyophilised and aqueous anti-cd40 antibody formulations
02/13/2014US20140046039 Antibodies directed against influenza
02/13/2014US20140046037 Novel immunoglobulin-binding proteins with improved specificity
02/13/2014US20140046036 Method for cancer immunotherapy
02/13/2014US20140046034 Antibody having activity of inhibiting hepatitus c virus (hcv) infection and use thereof
02/13/2014US20140046033 Antibodies with enhanced antibody-dependent cellular cytotoxicity activity, methods of their production and use
02/13/2014US20140046032 Method of production of sialylated antibodies
02/13/2014US20140046031 Anti-IL-23 Antibodies, Compositions, Methods and Uses
02/13/2014US20140046030 Antibodies comprising site-specific non-natural amino acid residues, methods of their preparation and methods of their use
02/13/2014US20140045760 Neurotoxins exhibiting shortened biological activity
02/13/2014US20140045242 Novel Strategies for Improved Cancer Vaccines
02/13/2014US20140045215 Neutralizing anti-ccl20 antibodies
02/13/2014US20140045195 Activatable Binding Polypeptides and Methods of Identification and Use Thereof
02/13/2014US20140044739 CDIM Binding Proteins And Uses Thereof
02/13/2014US20140044738 Antibodies And Other Molecules That Bind B7-H1 And PD-1
02/13/2014US20140044733 Antibody based reagent that specifically recognizes toxic oligomeric form of beta-amyloid
02/13/2014US20140044732 Nucleic Acids Encoding Antibody Molecules Which Bind IL-17A and IL-17F
02/13/2014US20140044730 ANTI-PCSK9 ANTIBODIES WITH pH-DEPENDENT BINDING CHARACTERISTICS
02/13/2014US20140044729 Antibody and antigen recognizing tumor-initiating cells and use thereof
02/13/2014US20140044728 Anti-tim-3 antibody
02/13/2014US20140044726 Preparations and methods for treating malignancies
02/13/2014US20140044725 Alzheimer's disease treatment method
02/13/2014US20140044724 Anti-endoglin antibodies and knockin mice expressing novel human/mouse chimeric endoglin
02/13/2014US20140044723 Anti-platelet membrane glycoprotein vi monoclonal antibody
02/13/2014US20140044722 Anti-sod1 antibodies and uses thereof
02/13/2014US20140044721 Anti-gb3 antibodies useful in treating disorders associated with angiogenesis
02/13/2014US20140044720 Human monoclonal antibodies that bind insulin-like growth factor (igf) i and ii
02/13/2014US20140044719 Antibodies against human respiratory syncytial virus (rsv) and methods of use
02/13/2014US20140044718 Antibodies against il-17br
02/13/2014US20140044716 Vhnar anti-cytokine domains
02/13/2014US20140044714 Human monoclonal antibodies specific for glypican-3 and use thereof
02/13/2014US20140044713 Compounds
02/13/2014US20140044711 Therapeutic Nuclease Compositions and Methods
02/13/2014US20140044707 ANTIBODIES THAT BIND HUMAN PROTEIN TYROSINE PHOSPHATASE beta (HPTPbeta) AND USES TEHREOF
02/13/2014US20140044704 Treatment of metastatic breast cancer
02/13/2014US20140044703 Human monoclonal antibody human cd134 (ox40) and methods of making and using same
02/13/2014US20140044675 Interleukin-2 fusion proteins and uses thereof
02/13/2014US20140044674 Interleukin-10 fusion proteins and uses thereof
02/13/2014US20140044645 Diagnosis and treatments relating to th2 inhibition
02/13/2014US20140044641 Polypeptides and polynucleotides, and uses thereof for treatment of immune related disorders and cancer
02/13/2014US20140044639 Antibody Therapy
02/13/2014CA2876285A1 Interleukin-10 fusion proteins and uses thereof
02/12/2014EP2695938A1 Antibody production method
02/12/2014EP2695935A1 Method for producing sheet-like pancreatic islet
02/12/2014EP2695897A1 Novel anti-human il-23 receptor antibody
02/12/2014EP2695896A2 Prevention of tissue ischemia, related methods and compositions
02/12/2014EP2695889A1 Protein purification by ion exchange
02/12/2014EP2694555A1 Cell-penetrating anti-dna antibodies and uses thereof to inhibit dna repair
02/12/2014EP2694554A1 Methods and compositions for normalization of tumor vasculature by inhibition of loxl2
02/12/2014EP2694553A2 T cell receptor-like antibodies specific for a wt1 peptide presented by hla-a2
02/12/2014EP2694552A1 Novel egfr binding proteins
02/12/2014EP2694551A1 Anti-fgfr4 antibodies and methods of use
02/12/2014EP2694550A1 Recombinant tnf ligand family member polypeptides with antibody binding domain and uses thereof
02/12/2014EP2694549A1 Anti-epidermal growth factor receptor variant iii chimeric antigen receptors and use of same for the treatment of cancer
02/12/2014EP2694548A1 Hmgb1 specific monoclonal antibodies
02/12/2014EP2694547A1 Antibodies that bind tgf-alpha and epiregulin
02/12/2014EP2694546A1 Bispecific binding molecules binding to vegf and ang2
1 ... 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 ... 1494